{"news_desk": "Business", "print_page": "1", "subsection_name": null, "section_name": "Business Day", "byline": {"original": "By ANDREW POLLACK", "person": [{"firstname": "Andrew", "rank": 1, "lastname": "POLLACK", "organization": "", "role": "reported"}]}, "abstract": "Elizabeth Holmes, founder of embattled blood-testing company Theranos, discusses her company\u2019s technology and data for first time in scientific meeting at annual American Assn for Clinical Chemistry in Philadelphia; says company is seeking approval of Zika virus detection test and introduces miniLab, box-sized table-top lab testing machine; presentation draws skepticism from laboratory specialists.", "type_of_material": "News", "word_count": "994", "keywords": [{"rank": "1", "value": "Theranos Inc", "is_major": "Y", "name": "organizations"}, {"rank": "2", "value": "Laboratories and Scientific Equipment", "is_major": "N", "name": "subject"}, {"rank": "3", "value": "Tests (Medical)", "is_major": "N", "name": "subject"}, {"rank": "4", "value": "Holmes, Elizabeth (1984- )", "is_major": "Y", "name": "persons"}, {"rank": "5", "value": "Philadelphia (Pa)", "is_major": "N", "name": "glocations"}, {"rank": "6", "value": "American Assn for Clinical Chemistry", "is_major": "N", "name": "organizations"}, {"rank": "7", "value": "Zika Virus", "is_major": "Y", "name": "subject"}, {"rank": "8", "value": "Blood", "is_major": "Y", "name": "subject"}], "lead_paragraph": "Elizabeth Holmes, chief executive, introduced technology called the miniLab, suggesting a new business model for the embattled blood-testing company.", "pub_date": "2016-08-02T00:00:00Z", "document_type": "article", "source": "The New York Times", "snippet": "Elizabeth Holmes, chief executive, introduced technology called the miniLab, suggesting a new business model for the embattled blood-testing company....", "multimedia": [{"height": 126, "subtype": "wide", "legacy": {"widewidth": "190", "wide": "images/2016/08/02/business/02THERANOS-2/02THERANOS-2-thumbWide.jpg", "wideheight": "126"}, "type": "image", "width": 190, "url": "images/2016/08/02/business/02THERANOS-2/02THERANOS-2-thumbWide.jpg"}, {"height": 400, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2016/08/02/business/02THERANOS-2/02THERANOS-2-articleLarge.jpg"}, "type": "image", "width": 600, "url": "images/2016/08/02/business/02THERANOS-2/02THERANOS-2-articleLarge.jpg"}, {"height": 75, "subtype": "thumbnail", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2016/08/02/business/02THERANOS-2/02THERANOS-2-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "url": "images/2016/08/02/business/02THERANOS-2/02THERANOS-2-thumbStandard.jpg"}], "web_url": "http://www.nytimes.com/2016/08/02/business/theranos-embattled-laboratory-shifts-to-medical-machines.html", "slideshow_credits": null, "blog": [], "_id": "579fe5cd38f0d861602e1aaa", "headline": {"main": "Theranos, Embattled Laboratory, Shifts to Medical Machines", "print_headline": "Theranos Shifts to Medical Testing Machines"}}